Skip to main content

Main menu

  • About Us
    • Leadership
    • Our Team
    • Vision, Mission and Values
    • Health and Economic Impact
    • Research Impact Video
    • Strategic Plan
  • Our Research
    • Research Focus
      • Brain Health
      • Cancer
      • Digital Health and Artificial Intelligence
      • Heart Health
      • Healthy Aging and Mobility
      • Immune System
      • Injury and Rehabilitation
      • Lung Health
      • Mental Health and Substance Use
    • Research Centres and Programs
      • BC Centre on Substance Use
      • Centre for Aging SMART
      • Centre for Clinical Epidemiology and Evaluation
      • Centre for Lung Health
      • Dilawri Cardiovascular Institute
      • Djavad Mowafaghian Centre for Brain Health
      • Immunity and Infection Research Centre
      • International Collaboration On Repair Discoveries
      • M. H. Mohseni Institute of Urologic Sciences
      • Ovarian Cancer Research Centre
      • Community Research Program
      • Emergency Medicine Research Program
      • Hematology Research Program
      • Skin Research Program
      • Other Research Focus Areas
    • News and Stories
    • Researcher Directory
    • Events and Workshops
  • Research Services
    • New to VCHRI
      • Working at VCHRI
      • Regulations and Training
      • Membership with VCHRI
      • Learning and Development
    • Starting Your Project
      • Research Facilitation
      • Awards and Funding
      • Grant Management
      • Operational Approval
      • CST Cerner
    • Developing Your Project
      • Clinical Trials Administration
      • Clinical Research Unit
      • Research Privacy
      • Financial Policies and Procedures
    • Additional Support
      • Indigenous Health Research Unit
      • VCH-VCHRI AI Hub
      • Communications and Media Relations
      • Study Recruitment Support
      • Innovation and Industry Partnership
    • Internal Awards
    • Clinical Research
    • Indigenous Research
  • Participate in Research
    • Reasons to Participate
    • Participant Stories
    • Find a Study
    • Recruitment Support

User menu

  • Log in

Breadcrumb

  1. Home
  2. Our Research
  3. Wai-Ching Lam

Wai-Ching Lam

Clinical Professor
Academic Appointment
Clinical Professor
Research Focus
Eyes and Vision
Contact Info
waiching.lam@vch.ca
604-875-4199
wai-ching-lam-027b3255/

Biography

Dr. Wai-Ching Lam is a clinical professor at the University of British Columbia (UBC) and head of the Ophthalmology Department at both Vancouver General Hospital and UBC Hospital. From 2016 to 2022, he served as a clinical professor at the University of Hong Kong and the ophthalmology chief of service at Queen Mary Hospital/Grantham Hospital and HKU-Shenzhen Hospital. Prior to 2016, he spent over 30 years at the University of Toronto, where he held several leadership roles, including vice chair of education, continuing education director, residency program director and vitreo-retinal fellowship director.

Dr. Lam is a vitreo-retinal surgeon with clinical interests in both adult and pediatric retinal diseases. In recognition of his clinical and scientific work, he has received the Achievement Award from the American Academy of Ophthalmology and Asian Pacific Academy of Ophthalmology, as well as the Fellow and the Senior Honor Award from the American Society of Retinal Specialists. He has published over 110 peer-reviewed articles, authored 7 book chapters and recently co-edited the book “A Quick Guide Pediatric Retina.”
 

Publications

  • Marine drugs -

    Bioactive Glial-Derived Neurotrophic Factor from a Safe Injectable Collagen-Alginate Composite Gel Rescues Retinal Photoreceptors from Retinal Degeneration in Rabbits.

    Hu T, Zhou T, Goit RK, Tam KC, Chan YK, Lam WC, Lo ACY
  • Advanced science (Weinheim, Baden-Wurttemberg, Germany) -

    Red Light-Triggered Anti-Angiogenic and Photodynamic Combination Therapy of Age-Related Macular Degeneration.

    Xu S, Cui K, Long K, Li J, Fan N, Lam WC, Liang X, Wang W
  • Antioxidants (Basel, Switzerland) -

    mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases.

    Wang Y, Fung NSK, Lam WC, Lo ACY
  • Cell death & disease -

    Involvement of FSP1-CoQ{{sub}}10{{/sub}}-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis.

    Yang M, Tsui MG, Tsang JKW, Goit RK, Yao KM, So KF, Lam WC, Lo ACY
  • International journal of molecular sciences -

    Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?

    Yang M, So KF, Lam WC, Lo ACY
Working in the lab

Are you a researcher?

Update or create your researcher profile on our online directory.

Update Profile    Create New Profile

Get updates!

Join our newsletter mailing list to stay up to date on features and releases.

Subscribe

Quick Links

  • News and Stories
  • Careers
  • Events
  • Media Enquiries

Follow Us

  • LinkedIn
  • X
  • YouTube

© 2025 VCHRI. All rights reserved.

  • Contact
  • Privacy Policy